Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.56	9.99	13.01	17.8	7.16	16.6
Short-Term Investments	16.07	31.34	52.75	89.32	140.46	-
Cash & Short-Term Investments	28.63	41.34	65.76	107.12	147.62	16.6
Cash Growth	-45.25%	-37.14%	-38.61%	-27.44%	789.50%	6511.95%
Prepaid Expenses	0.83	0.47	1.17	1.13	0.55	1.38
Other Current Assets	0.12	0.12	0.33	0.34	0.37	2.11
Total Current Assets	29.57	41.93	67.25	108.59	148.54	20.08
Property, Plant & Equipment	2.19	3.38	7.04	9.72	4.64	1.27
Other Long-Term Assets	0.02	0.05	0.09	0.06	0.04	0.09
Total Assets	31.78	45.36	74.37	118.38	153.23	21.43
Accounts Payable	0.35	0.24	0.57	4.47	2.46	3.88
Accrued Expenses	1.48	2.73	2.41	2.46	1.75	0.92
Current Portion of Leases	1.96	2.32	2.44	2.13	0.68	0.03
Other Current Liabilities	0.08	0.16	0.22	-	-	-
Total Current Liabilities	3.87	5.45	5.64	9.07	4.89	4.83
Long-Term Debt	-	-	-	-	-	0.57
Long-Term Leases	0.6	1.53	3.77	5.9	1.67	0.09
Other Long-Term Liabilities	-	-	0.07	-	0.15	0.05
Total Liabilities	4.47	6.98	9.48	14.97	6.71	5.54
Common Stock	-	0	0	0	0	-
Additional Paid-In Capital	301.18	300.45	297	302.2	296.05	55.97
Retained Earnings	-273.85	-262.05	-231.9	-197.79	-149.21	-112.41
Comprehensive Income & Other	-0.01	-0.01	-0.21	-1	-0.33	-
Total Common Equity	27.31	38.39	64.9	103.41	146.51	-56.44
Shareholders' Equity	27.31	38.39	64.9	103.41	146.51	15.89
Total Liabilities & Equity	31.78	45.36	74.37	118.38	153.23	21.43
Total Debt	2.56	3.85	6.21	8.03	2.35	0.69
Net Cash (Debt)	26.07	37.49	59.55	99.08	145.27	15.91
Net Cash Growth	-44.82%	-37.04%	-39.90%	-31.79%	813.00%	-
Net Cash Per Share	20.70	29.85	42.61	64.54	104.85	197.39
Filing Date Shares Outstanding	1.26	1.26	1.25	1.55	1.53	1.53
Total Common Shares Outstanding	1.26	1.26	1.25	1.54	1.53	0.09
Working Capital	25.7	36.48	61.61	99.52	143.65	15.25
Book Value Per Share	21.66	30.49	51.85	67.23	95.73	-601.92
Tangible Book Value	27.31	38.39	64.9	103.41	146.51	-56.44
Tangible Book Value Per Share	21.66	30.49	51.85	67.23	95.73	-601.92
Machinery	0.37	1.66	2.64	3.24	5.58	1.86
Leasehold Improvements	0.25	0.25	0.25	0.25	0.25	-

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q